Morning Sickness Pill Back on the Market

Now here’s some news Kate Middleton could’ve used months ago! Bendectin, a drug specifically designed to combat morning sickness, is returning after a 30-year absence. The pill had been pulled off the market after there were concerns about it causing birth defects, but a new FDA study found that the drug is “a safe and effective treatment.” “We know safety-wise, there’s zero question,” Dr. Gary Hankins of the University of Texas Medical Branch in Galveston told the Associated Press. Now called Diclegis, the drug combines Vitamin B6 and the over-the-counter antihistamine doxylamine with a delayed-release coating “designed to help women take a daily dose before their nausea sets in,” according to the AP. Diclegis is expected to hit store shelves in June.

Share:

Join Our Mailing List

Recent Articles

Hey! Are you enjoying NYCTastemakers? Make sure to join our mailing list for NYCTM and never miss the chance to read all of our articles!